AI Summary
✦ ClarthaPrice Forecast
Probabilistic Range
Probabilistic lognormal cone using 1Y realized volatility and analyst-target drift when available.
Revenue Forecast
₹ CrEPS Forecast
₹ / shareMulti-factor synthesis of 5 key dimensions
Analyst coverage unavailable
Fundamentals
Fundamentals institutional score is 60 using EVA spread proxy 6.5%; growth durability 19.8.
Valuation
Valuation institutional score is 25 using relative multiple z-scores where peer dispersion is available.
Analyst Consensus
No usable analyst target or recommendation data was available.
Technical Structure
Technicals institutional score is 43 using EMA-20 continuation within 5% tolerance; VCP range/volume contraction proxy.
Market Sentiment
Recent news flow is balanced or not decisive enough to tilt the tape. Based on 8 recent ticker-linked news items.
Signal Summary
Market intelligence remains Mixed. Available evidence provides partial support, while valuation and technical structure remain considerations.
Composite weights: Fundamentals 25%, Valuation 20%, Analyst Consensus 20%, Technical Structure 20%, Market Sentiment 15%.
Key Data Points
Important Note: This is market intelligence, not investment advice. Always conduct your own research and consider your financial goals and risk tolerance.
Valuation Metrics
Forward outlook is unavailable because live next-12-month estimate data is not available for this ticker right now.
5Y Average
12.88
Current
16.71
Overvalued
15.53
Undervalued
10.28
5Y Average
—
Current
3.88
Overvalued
4.46
Undervalued
3.30
Peers & Comparison
No sector data available for this company.
Financials
Real statement data for revenue, earnings quality, conversion, and balance-sheet coverage. Monetary values are shown in Rs crore.
Latest revenue
₹110 CrMar 2026Latest net profit
₹22 CrMar 2026Latest EPS
₹7.33Mar 2026Net margin
20.0%Mar 2026Performance
Bars show revenue and net profit. The line shows net margin.
- Revenue
- Net income
- Net margin %
Earnings
Revenue is shown in crores. EPS is rupees per share.
- Revenue
- EPS
Revenue to profit conversion
Bridge from operating numbers to profit for the latest reported period.
Latest reported period: Mar 2026
Debt level and coverage
Debt, cash and free cash flow compared on the same crore scale.
- Debt
- Free cash flow
- Cash & equivalents
Results
| Metric | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales + | 101 | 77 | 51 | 89 | 90 | 73 | 90 | 146 | 122 | 119 | 107 | 114 | 110 |
| Expenses + | 75 | 64 | 63 | 63 | 81 | 71 | 74 | 96 | 89 | 96 | 84 | 91 | 88 |
| Operating Profit | 25 | 13 | -12 | 26 | 9 | 2 | 15 | 50 | 33 | 23 | 23 | 23 | 22 |
| OPM % | 25% | 17% | -23% | 30% | 10% | 2.5% | 17% | 34% | 27% | 19% | 21% | 21% | 20% |
| Other Income + | -14 | 2 | -7 | 3 | 2 | 3 | 3 | 2 | 4 | 9 | 6 | 1 | 15 |
| Interest | 6 | 5 | 4 | 5 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
| Depreciation | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 |
| Profit before tax | -1 | 5 | -28 | 18 | 1 | -5 | 9 | 42 | 28 | 23 | 21 | 17 | 29 |
| Tax % | 173% | 0% | 0% | 34% | 994% | 0% | 8% | 18% | -5% | 29% | 29% | 29% | 26% |
| Net Profit + | -2 | 5 | -28 | 12 | -7 | -5 | 8 | 35 | 29 | 16 | 15 | 12 | 22 |
| EPS in Rs | -0.72 | 1.63 | -9.51 | 3.98 | -2.46 | -1.65 | 2.77 | 11.89 | 9.96 | 5.51 | 5.00 | 4.00 | 7.33 |
| Raw PDF |
All values in ₹ Crores unless otherwise stated. Source: Screener Master (Standalone).
Events Timeline
Board Meeting Intimation for Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30, 2026.
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Intimation Regarding Listing Of Equity Shares Of Fermenta Biotech Limited On National Stock Exchange Of India Limited.